USE OF MODIFIED OLIGO-BETA-(1,3)-GLUCANS FOR TREATING DISEASES OF THE IMMUNE SYSTEM, OLIGO- BETA - (1,3)-GLUCAN-(1,3)- MANNOSE, OLIGO- BETA -(1,3)-GLUCAN-(1,3)- MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THEM
The present invention relates to the use of at least one compound of the formula (I)or (II), in which Ri is H and n is an integer from 2 to 10, in the preparation of a drugfor treating diseases from the group comprising tumour, cancer, viral disease,bacterial disease, fungal disease, immune system disease, auto-immune diseaseor disease associated with a Pimmunostimulation deficiency in human beingsand warm-blood animals. The invention also relates to new products having a mannoseor mannitol termination as well as a method for preparing the same.
